Obsidian Therapeutics, Inc. · NASDAQ:OBX
Obsidian Therapeutics, Inc. shareholders
As of Sep 30, 2026, 58 institutions reported holding Obsidian Therapeutics, Inc., 83.7% of its shares. Largest: Ra Capital Management, L.P., Atlas Venture Life Science Advisors, LLC and Paradigm Biocapital Advisors LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Obsidian Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 5.96M | 9.6% | new | Nov 16, 2026 |
| Atlas Venture Life Science Advisors, LLC | 4.5M | 7.3% | new | Nov 10, 2026 |
| Paradigm Biocapital Advisors LP | 4.16M | 6.7% | new | Nov 16, 2026 |
| Novo Holdings A/S | 3.12M | 5.1% | new | Nov 16, 2026 |
| Vanguard | 2.75M | 4.5% | new | Nov 13, 2026 |
| Trails Edge Capital Partners, LP | 2.5M | 4.0% | new | Nov 16, 2026 |
| Octagon Capital Advisors LP | 2.41M | 3.9% | new | Nov 16, 2026 |
| TCG Crossover Management, LLC | 2.2M | 3.6% | new | Nov 16, 2026 |
| Deep Track Capital, LP | 2.12M | 3.4% | new | Nov 16, 2026 |
| Citadel | 1.95M | 3.2% | new | Nov 16, 2026 |